Exhibit 99

            CERTIFICATION OF CHIEF FINANCIAL OFFICER
               PURSUANT TO 18 U.S.C. SECTION 1350,
                     AS ADOPTED PURSUANT TO
          SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection with the IGENE Biotechnology, Inc. (the "Company")
Quarterly  Report on Form 10-QSB for the period  ended  September
30, 2002, as filed with the Securities and Exchange Commission on
the  date  hereof (the "Report"), I, Edward J. Weisberger,  Chief
Financial  Officer of the Company, certify pursuant to 18  U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-
Oxley Act of 2002, that, to the best of my knowledge:

          (1). The Report fully complies with the requirements of
          Section  13(a) or 15(d) of the Securities Exchange  Act
          of 1934, as amended; and

          (2).  The  information contained in the  Report  fairly
          presents,  in  all  material  respects,  the  financial
          condition and results of operations of the Company.


Date: March 31, 2003             By:  /s/EDWARD J. WEISBERGER
                                      ___________________________
                                         EDWARD J. WEISBERGER
                                         Chief Financial Officer